Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Dose Phase I Study to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Stem Cells Lenses in the Chronic Ocular Graft-versus-Host Disease Subjects

NCT06952114 is registered in ClinicalTrials.gov with Guangdong ProCapZoom Biosciences Co., Ltd. as lead sponsor.

NCT NCT06952114
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06952114 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Dose Phase I Study to Evaluate the Safety, Tolerability and Preliminary Effectiveness of Stem Cells Lenses in the Chronic Ocular Graft-versus-Host Disease Subjects
Lead sponsor
Guangdong ProCapZoom Biosciences Co., Ltd.
Phase
Phase 1
Overall status
Not yet recruiting
Start date
May 20, 2025
Completion date
February 28, 2026
Enrollment
6 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic ocular graft-versus-host disease